Business Wire

HANSHOW

8.6.2021 04:02:06 CEST | Business Wire | Press release

Share
Hanshow Marks Retail Digitization at Breakthrough Scale on Microsoft Azure

Deploying scalable and affordable enterprise grade IoT applications in the retail industry has previously been restricted by technology limitations. But digital retail solutions leader Hanshow has now developed a SaaS solution that accelerates this digital transformation by connecting store shelves to retailers, store operators, and customers on an unprecedented scale by managing more than 10 million IoT devices across a vast network of Ahold Delhaize stores in Europe.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210607005244/en/

Ahold Delhaize and Hanshow began partnering in 2018 to install electronic shelf labels (ESL) and other digital solutions at select stores in Europe. This later expanded to cover hundreds of stores across Europe and over 10 million ESL – a tremendous number of devices to sync and manage.

ESLs are the building blocks of retail digitization, and effective solutions for connecting them are crucial to maximize efficiency and open up new digital solution possibilities. However, the ability to remotely manage tens of millions of ESL across hundreds of stores through one cloud-based network had not yet been possible until Hanshow partnered with Microsoft to develop a SaaS solution that can handle this massive amount of integration.

Adopting solutions through cloud services and IoT technology is rapidly growing in retail. Global research firm Gartner estimates, “Worldwide end-user spending on public cloud services is forecast to grow 18.4% in 2021 to total $304.9 billion, up from $257.5 billion in 2020”.* It further adds, “Although software as a service (SaaS) remains the largest market segment and is forecast to grow to $117.7 billion in 2021, application infrastructure services (PaaS) is anticipated to grow by a higher margin at 26.6%” *

The benefits of adopting such services are apparent through this partnership. The Hanshow SaaS solution addresses a number of challenges for retailers such as staffing surges during peak times, labor costs, space constraints, and overall productivity.

Under previous scenarios, retailers have to install and operate their own system of servers and infrastructure on premise requiring a massive investment, untold time to set up, and significant input from IT professionals.

The Hanshow SaaS Solution provides global retailers an intelligent, easy-to-deploy, user-friendly, and analytics driven platform. Hanshow SaaS is ready on arrival and can be accessed instantly anytime, anywhere. Data can be shared across geographies while remote monitoring and updates become a seamless exercise. Price updates and other ESL or digital solution updates can be done at breakneck pace; 3 million ESL can be updated in just 80 min. And with a focus on the heightened security needed from a cloud-based network, Hanshow carried out third-party security testing through a leading global security firm to certify data safety of the Microsoft Azure backed Hanshow SaaS.

“This scale and advancement in retail technology was made possible through the safety, stability, scalability and speed of Microsoft SaaS with Hanshow’s innovative management software,” said Raj Raguneethan, regional leader, Retail & Consumer Goods at Microsoft Asia. “With this work, we’re seeing only the beginning of what’s possible with IoT and SaaS.”

While over 10 million ESL have already integrated into the Hanshow SaaS, it can handle much more if necessary. “By integrating retail digitization with SaaS, the possibilities are endless,” said Hanshow Executive Chairman and CEO Shiguo Hou. “This is the future. We're committed to bringing these benefits to customers and retailers on an even grander scale.”

*Gartner Press Release, “Gartner Forecasts Worldwide Public Cloud End-User Spending to Grow 18% in 2021”, 17 November 2020, [https://www.gartner.com/en/newsroom/press-releases/2020-11-17-gartner-forecasts-worldwide-public-cloud-end-user-spending-to-grow-18-percent-in-2021 ]

About Hanshow

Hanshow is a global leader in developing and manufacturing electronic shelf labels and digital store solutions. As an innovation leader in the industry, Hanshow is dedicated to offering its global customers a series of world-class customized IoT touchpoints and digital store solutions. Hanshow’s intelligence-enabled platforms and systems deliver customer-centric insights, helping retailers streamline operations and providing various solutions to support optimal pricing strategies to offer consumers a more personalized experience. Hanshow currently serves over 20,000 stores in more than 50 countries. For more information, please visit www.hanshow.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release

- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release

Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s

DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 17:08:00 CEST | Press release

HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l

BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 202612.6.2026 12:00:00 CEST | Press release

Tacabrutideg (BGB-16673, BTK degrader) showed durable responses in heavily pretreated R/R CLL and BTK inhibitor–naïve patients, signaling potential for earlier lines of treatmentBRUKINSA plus sonrotoclax (ZS) delivered deep, durable responses and high uMRD rates across TN CLL and R/R MCL and CLL, reinforcing its potential as an all-oral, fixed-duration treatment BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from its foundational hematology franchise at the 2026 European Hematology Association (EHA) Congress in Stockholm. Updated results from tacabrutideg (BGB-16673), a potential best-in-class Bruton’s tyrosine kinase (BTK) degrader, demonstrated durable responses in pretreated relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), with early activity also seen in BTK inhibitor–naïve patients. These data are complemented by results from the all-oral combination of BRUKINSA® (zanubru

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye